Targeting PPAR receptors in the airway for the treatment of inflammatory lung disease.
Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors that belong to the nuclear hormone receptor superfamily. PPARgamma regulates several metabolic pathways by binding to sequence-specific PPAR response elements in the promoter region of genes involved in lipid biosynthesis and glucose metabolism. However, more recently PPARgamma, PPARalpha and PPARbeta/delta agonists have been demonstrated to exhibit anti-inflammatory and immunomodulatory properties thus opening up new avenues for research. The actions of PPARgamma and PPARalpha activation are thought to be due to their ability to down regulate pro-inflammatory gene expression and inflammatory cell functions, and as such makes them an attractive target for novel drug intervention. Interestingly, PPARbeta/delta has been shown to be involved in wound healing, angiogenesis, lipid metabolism and thrombosis. In this review we will focus on the data describing the beneficial effects of these ligands in the airway and in the pulmonary vasculature and in vivo in animal models of allergic and occupational asthma, chronic obstructive pulmonary disease and pulmonary fibrosis. A clinical trial is underway to examine the effect of rosiglitazone in asthma patients and the outcome of this trial is awaited with much anticipation. In conclusion, PPARs are novel targets for lung disease and continued work with these ligands may result in a potential new treatment for chronic inflammatory lung diseases.
Belvisi
Maria G
MG
Respiratory Pharmacology Group, National Heart & Lung Institute, Faculty of Medicine, Imperial College, London, UK. m.belvisi@imperial.ac.uk
Mitchell
Jane A
JA
D001249:Asthma / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D008171:Lung Diseases / Q000188:drug therapy* / Q000378:metabolism; D047492:Peroxisome Proliferator-Activated Receptors / Q000378:metabolism*; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy* / Q000378:metabolism; D011658:Pulmonary Fibrosis / Q000188:drug therapy* / Q000378:metabolism
D047492:Peroxisome Proliferator-Activated Receptors
J Biol Chem. 2002 Mar 1;277(9):6838-45
11726654
J Immunol. 2003 Mar 1;170(5):2663-9
12594295
Nature. 1996 Nov 7;384(6604):23-4
8900268
Br J Pharmacol. 2003 May;139(1):163-71
12746235
Int Arch Allergy Immunol. 2004 Jun;134 Suppl 1:30-6
15166481
Respir Res. 2007 Dec 04;8:90
18053220
Blood. 2004 Sep 1;104(5):1361-8
15130939
J Allergy Clin Immunol. 2004 May;113(5):882-8
15131570
Thorax. 2003 Sep;58(9):778-83
12947137
J Biol Chem. 2000 Sep 8;275(36):28028-32
10827178
Prostaglandins Other Lipid Mediat. 2007 Jan;82(1-4):68-76
17164134
Am J Physiol Lung Cell Mol Physiol. 2008 May;294(5):L891-901
18162602
Eur Respir J. 2005 Feb;25(2):225-34
15684285
J Biol Chem. 2000 Feb 18;275(7):4541-4
10671476
Mol Cell. 2007 Jan 12;25(1):57-70
17218271
Chest. 2008 Jul;134(1):152-7
18628217
Trends Pharmacol Sci. 2005 May;26(5):244-51
15860371
Circ Res. 2006 Feb 17;98(3):361-9
16397146
Am J Pathol. 2004 Jan;164(1):263-71
14695339
J Cell Biol. 2007 Feb 26;176(5):681-94
17325208
Cell. 1995 Dec 1;83(5):813-9
8521498
Endocr Rev. 1999 Oct;20(5):649-88
10529898
Science. 1988 May 13;240(4854):889-95
3283939
Mol Pharmacol. 2008 Feb;73(2):323-37
17984196
Antioxid Redox Signal. 2008 Feb;10(2):253-60
17970647
Lancet. 2005 Oct 8;366(9493):1279-89
16214598
Biochem Biophys Res Commun. 2001 May 4;283(2):344-6
11327705
Eur Respir J. 2007 Aug;30(2):245-52
17459894
Arch Biochem Biophys. 2003 Oct 15;418(2):186-96
14522590
Cell. 1998 Apr 17;93(2):241-52
9568716
PPAR Res. 2007;2007:71323
17710235
Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7614-9
9636198
Am J Respir Cell Mol Biol. 2006 Feb;34(2):242-6
16239641
J Immunol. 2003 May 15;170(10):5295-301
12734379
Endocrinology. 1996 Jan;137(1):354-66
8536636
J Biol Chem. 1998 Oct 2;273(40):25573-80
9748221
FEBS J. 2006 Jan;273(1):170-9
16367757
J Exp Med. 2003 Aug 4;198(3):411-21
12900517
N Engl J Med. 2004 Sep 9;351(11):1106-18
15356308
Am J Respir Cell Mol Biol. 2001 Jun;24(6):688-93
11415933
Am J Respir Cell Mol Biol. 2001 Jun;24(6):658-61
11415929
Nature. 1998 Jan 1;391(6662):79-82
9422508
Mol Endocrinol. 2007 Aug;21(8):1756-68
17488971
Lancet. 2002 Nov 2;360(9343):1410-8
12424006
Diabetes. 2000 Mar;49(3):346-55
10868955
J Biol Chem. 1983 Oct 10;258(19):11713-8
6578214
Respir Res. 2005 Aug 09;6:91
16091136
Eur J Pharmacol. 2006 Mar 8;533(1-3):101-9
16458290
Circ Res. 2003 May 30;92(10):1162-9
12714563
Am J Physiol Lung Cell Mol Physiol. 2006 Jul;291(1):L84-90
16443643
Trends Immunol. 2007 Dec;28(12):551-8
17981503
Shock. 2005 Dec;24(6):547-55
16317386
Expert Opin Ther Targets. 2004 Aug;8(4):265-85
15268623
Nature. 1998 Jan 1;391(6662):82-6
9422509
Eur Respir J. 2004 Jul;24(1):18-23
15293600
Am J Physiol Lung Cell Mol Physiol. 2005 Jun;288(6):L1146-53
15734787
J Biol Chem. 1999 Nov 5;274(45):32048-54
10542237
Science. 2003 Oct 17;302(5644):453-7
12970571
Cell. 1995 Dec 1;83(5):803-12
8521497
Exp Physiol. 2008 Jan;93(1):141-7
17965142
Curr Opin Cell Biol. 1998 Jun;10(3):384-91
9640540
J Med Chem. 2000 Feb 24;43(4):527-50
10691680
Pulm Pharmacol Ther. 2006;19(1):39-46
16286236
Hypertension. 2002 Nov;40(5):687-93
12411463
Gastroenterology. 2007 Jul;133(1):108-23
17631136
Endocrinology. 1996 Oct;137(10):4189-95
8828476
FASEB J. 2006 Feb;20(2):326-8
16368717
Clin Exp Allergy. 2006 Dec;36(12):1494-504
17177672
J Immunol. 2006 Oct 15;177(8):5248-57
17015710
Curr Opin Pharmacol. 2006 Jun;6(3):263-70
16580256
Proc Am Thorac Soc. 2006 Aug;3(6):510-1
16921131
Nature. 1999 Jul 22;400(6742):378-82
10432118
Clin Immunol. 2005 Feb;114(2):100-9
15639643
FEBS Lett. 2004 Aug 13;572(1-3):33-40
15304320
Eur J Pharmacol. 2003 Nov 28;481(2-3):261-9
14642794
Fundam Clin Pharmacol. 2006 Oct;20(5):429-47
16968414
Pharmacol Res. 2005 Feb;51(2):85-94
15629253
Inflamm Res. 2008 Jul;57(7):314-21
18622687
Nature. 1996 Nov 7;384(6604):39-43
8900274
Am J Respir Crit Care Med. 2004 Jan 15;169(2):195-200
14563653
Inflamm Res. 2005 Nov;54(11):464-70
16307220
Pharmacol Rev. 2006 Dec;58(4):726-41
17132851
Endocrinology. 1997 Sep;138(9):3695-703
9275054